Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Extreme Language Ultra-High Potency
The newest generation of small-molecule therapies bring containment needs well beyond those of conventional HPAPIs. What does this mean for the pharma lexicon – and the pharma landscape? read more
Should Sponsors Provide Source Document Templates?
Sponsor-provided templates provide a compelling opportunity to improve upstream trial execution. However, in today’s world of increasingly complex and data-driven trials, the opportunity comes with important caveats. read more
Post-Approval Change Management
Achieving global approval for a single change may take three to five years, but inefficient lifecycle change management rarely registers as a crisis. read more
How Real-Time Data Analytics Can Address Common Pain Points in Clinical Trials
Major issues in clinical oversight are latency and heterogeneity across systems including formats, identifiers, coding conventions, and timing of updates. read more

View More Editorial Articles »

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

View More Videos »

View More Whitepapers & Application Notes »

Mikart Appoints Chief Executive Officer
Tuesday, July 07, 2026
Mikart announced that Darrin T. Schellin has joined the company as Chief Executive Officer. read more
Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
Tuesday, July 07, 2026
Matica Biotechnology is partnering with VaxDome to bring its novel antigen-agnostic antiviral-vaccine hybrid candidates into clinical trials. read more
Vector Science & Therapeutics Signs Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus
Tuesday, July 07, 2026
Vector Science & Therapeutics has entered an exclusive licensing and manufacturing agreement with LyoGenesis Plus, a Wisconsin-based contract ... read more
Arcturus, Thermo Fisher Partner on Phase 3 Manufacturing for Cystic Fibrosis mRNA Therapy
Thursday, July 02, 2026
Arcturus Therapeutics has entered a strategic collaboration with Thermo Fisher Scientific to support late-stage development and potential ... read more
Lonza Acquires TfR1 Blood-Brain Barrier Technology from Nona, Expands Collaboration
Thursday, July 02, 2026
Lonza has acquired rights to Nona Biosciences’ transferrin receptor (TfR1)-based blood-brain barrier (BBB) technology and expanded its existing ... read more

View More News »

Mikart Appoints Chief Executive Officer
Tuesday, July 07, 2026
Matica Bio and VaxDome Partner to Develop Antigen-Agnostic Antiviral-Vaccine Hybrids with Influenza as One of the Disease Models
Tuesday, July 07, 2026
Vector Science & Therapeutics Signs Exclusive cGMP Manufacturing Agreement with LyoGenesis Plus
Tuesday, July 07, 2026

April/May/June 2026

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

AAPS Summer Scientific Forum 2026
Monday, July 13, 2026
3rd Cell & Gene Therapy Pricing & Reimbursement Summit
Tuesday, July 14, 2026
MedTech Validation: Smarter V&V, Design Controls, and Digital Device Files
Wednesday, July 22, 2026

View More Events »

2026 Company Focus & Industry Reference Guide
View Issue

Subscriptions

Get started here for yourcomplimentary print ordigital subscription

Get started here for your complimentary magazine subscription

Drug Product Design Enabling Rapid and Scalable Clinical Development
Tuesday, June 30, 2026
11:00 AM PT
JUN
30

More Webinars »